PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAYS FROM COP 2008:
+ The Prime Partner has changed from KEMRI to TBD.
COP 2008
WHO and CDC have developed a method to monitor the emergence of HIV drug resistance (HIVDR) during
the first year of antiretroviral treatment (ART) and evaluate potentially associated program factors which
could be altered to optimize ART program functioning for HIVDR prevention. A sample size of
approximately 100 patients initiating ART is evaluated at baseline and 12 months at 3-5 sentinel sites. At
baseline, a genotype and brief ARV history are taken. At 12 months, or at time of switch to a second-line
regimen, a viral load (VL), a genotype, and an adherence assessment are performed. Monitoring is defined
as the measurement and interpretation of viral suppression in populations taking first-line ART 12 months
after commencement of ART and the measurement and interpretation of HIVDR in populations commencing
ART and in populations not achieving viral suppression after 12 months of first-line ART. Data will assist the
Kenya Ministry of Health National AIDS and STI Control Program (NASCOP) and other national and
international partners to design strategies to improve ART outcomes and support recommendations for
optimal first- and second-line regimens and indications for time of regimen switch. This strategy will be
implemented along with early warning indicators available from routine ART clinical data. The sentinel
methodology will be incorporated as a routine evaluation. The completion of surveillance and data
collection using COP 08 funding is anticipated. Additional funding is requested in FY09 COP for data
analysis and report writing.
New/Continuing Activity: Continuing Activity
Continuing Activity: 17154
Table 3.3.09:
